Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Alpert

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Cancer Research|August 27, 1999
Deficiency of connexin43 gap junctions is an independent marker for breast tumorsD W Laird, P Fistouris, G Batist, et al.
The American Journal of Medicine|June 26, 1987
Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trialE J Goldstein, M L Alpert, A Najem, et al.
Gastroenterology|September 11, 1992
Selection of the chimpanzee over the baboon as a model for Helicobacter pylori infectionS L Hazell, J W Eichberg, D R Lee, et al.
Annals of the New York Academy of Sciences|September 15, 1971
The role of thymectomy in the treatment of myasthenia gravisV P Perlo, B Arnason, D Poskanzer, et al.
Circulation|January 1, 1991
Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study GroupR W Henthorn, A L Waldo, J L Anderson, et al.
Circulation|December 1, 1989
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study GroupJ L Anderson, E M Gilbert, B L Alpert, et al.
The Journal of Biological Chemistry|March 30, 2001
Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissueI Jaitovich-Groisman, N Benlimame, B L Slagle, et al.
Journal of the American College of Cardiology|March 1, 1992
Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators GroupS Saksena, M Poczobutt-Johanos, L W Castle, et al.
American Heart Journal|August 11, 1992
Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study GroupA K Bhandari, J L Anderson, E M Gilbert, et al.
Research in Nursing & Health|December 18, 2001
Improving cognitive development of low-birth-weight premature infants with the COPE program: a pilot study of the benefit of early NICU intervention with mothersB M Melnyk, L Alpert-Gillis, N F Feinstein, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancer Research|August 27, 1999
Deficiency of connexin43 gap junctions is an independent marker for breast tumorsD W Laird, P Fistouris, G Batist, et al.
The American Journal of Medicine|June 26, 1987
Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trialE J Goldstein, M L Alpert, A Najem, et al.
Gastroenterology|September 11, 1992
Selection of the chimpanzee over the baboon as a model for Helicobacter pylori infectionS L Hazell, J W Eichberg, D R Lee, et al.
Annals of the New York Academy of Sciences|September 15, 1971
The role of thymectomy in the treatment of myasthenia gravisV P Perlo, B Arnason, D Poskanzer, et al.
Circulation|January 1, 1991
Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study GroupR W Henthorn, A L Waldo, J L Anderson, et al.
Circulation|December 1, 1989
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study GroupJ L Anderson, E M Gilbert, B L Alpert, et al.
The Journal of Biological Chemistry|March 30, 2001
Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissueI Jaitovich-Groisman, N Benlimame, B L Slagle, et al.
Journal of the American College of Cardiology|March 1, 1992
Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators GroupS Saksena, M Poczobutt-Johanos, L W Castle, et al.
American Heart Journal|August 11, 1992
Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study GroupA K Bhandari, J L Anderson, E M Gilbert, et al.
Research in Nursing & Health|December 18, 2001
Improving cognitive development of low-birth-weight premature infants with the COPE program: a pilot study of the benefit of early NICU intervention with mothersB M Melnyk, L Alpert-Gillis, N F Feinstein, et al.
Pageof 8